Clinical Trial Update: Venetoclax + Azacitidine in Patients With Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for venetoclax plus azacitidine in acute myeloid leukemia, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Venetoclax (venetoclax)

Snippet

Sponsor: Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: RECRUITING